2013
DOI: 10.1016/j.spinee.2013.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacophysiology of bone and spinal fusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 93 publications
0
5
0
Order By: Relevance
“…Pharmacological treatment frequently includes bisphosphonates, because scientific evidence of their efficacy. 1,7,8,11,15 However, their effects on spine fusion are unclear. 18 It is reasonable that the spine surgeon refers the patient to the endocrinologist before surgery to optimize treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pharmacological treatment frequently includes bisphosphonates, because scientific evidence of their efficacy. 1,7,8,11,15 However, their effects on spine fusion are unclear. 18 It is reasonable that the spine surgeon refers the patient to the endocrinologist before surgery to optimize treatment.…”
Section: Discussionmentioning
confidence: 99%
“…6 Second is to treat patients with lifestyle recommendations and with medications to improve bone mineral density (BMD). 7,8 Third is management of complications related to OP that may occur during spine surgery.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the advancement of surgical techniques, pseudoarthrosis remains one of the most common complications, resulting in poor functional outcomes and increasing risk of reoperation after spinal fusion [6][7][8]. The process of bony fusion is a dynamic bone remodeling process [9]. A variety of risk factors have been identified to contribute to pseudoarthrosis, for example, osteoporosis, long-term steroid use, and smoking [7,8,10,11].…”
Section: Introductionmentioning
confidence: 99%
“…As prior studies have demonstrated, low bone mineral density is a significant risk factor for vertebral fracture, instrumentation failure, and pseudarthrosis, signifying the fundamental role bone health plays in the fusion process. [11][12][13][14][15][16][17][18][19][20][21] Until recently, although hypovitaminosis D (the accepted term for insufficient or deficient levels of vitamin D) was significantly associated with low bone mineral density, [22][23][24] the effect of vitamin D levels on outcomes following spinal fusion were not well studied. Within the past several years, literature has indicated that patients' bone and disc health as well as spinal fusion outcomes all may benefit from correcting their vitamin D levels.…”
Section: Introductionmentioning
confidence: 99%